Conversely, dysregulation of AMPK signaling and subsequent mitochondrial dysfunction in the skeletal muscle are frequently observed in the pathogenesis of human diseases, including obesity, type 2 diabetes, and muscular dystrophy/atrophy (3,4,16,17). Here, PRKAA1 is linked to muscular dystrophy.